SecBot SecBot
SC 13G/A ·Filed Nov 6, 2026

VTRS

Viatris Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 5h ago SEC0001036325-26-000035
Passive stake amendment
Actionable Insight • Neutral

The incremental increase is routine for a passive manager. Monitor the next 13F filing for any change in Davis Selected Advisers' position size relative to this disclosure.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$19.91
T+0 close · Nov 6, 2026 · via day close
Latest settled
+4.57%
T+5 · $20.82
Vs SPY
+1.98%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $19.91entry
  2. T+1 · 8d ago +2.91%α +0.55% · $20.49
  3. T+5 · 4d ago +4.57%α +1.98% · $20.82
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Davis Selected Advisers filed an amended Schedule 13G disclosing a 6.3% passive stake in Viatris as of September 30, 2026, up from 6.1% in the prior filing. The increase is routine for a passive investment manager and does not signal a change in investment thesis.

Key Financial Metrics

Stake
6.3%
Investor
Davis Selected Advisers
Investor Type
mutual fund

Key Facts

  • Davis Selected Advisers reported beneficial ownership of 72,403,329 shares of Viatris common stock as of September 30, 2026.
  • The stake represents 6.3% of shares outstanding, up from 6.1% in the prior filing (70,080,338 shares as of August 12, 2026).
  • The filing is a passive investment disclosure under Rule 13d-1(b).
  • The increase of approximately 2,323,000 shares is consistent with routine portfolio adjustments by a passive manager.

Financial Impact

Increase of approximately 2.3 million shares, stake value roughly $350M based on market cap of $22.1B and 6.3% stake.

ownership percentage

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001036325-26-000035
Document: 0001036325-26-000035-index.html0001036325-26-000035
Document: 0001036325-26-000035.txt0001036325-26-000035

Track record

22 reports on VTRS

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +16.85% at T+60 after the Aug 6, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 17, 2026today 8-K Neutral 4/10 Entry $20.51 Now $20.49 −0.10% settles Feb 16
  2. Nov 17, 2026today Press Release Neutral 4/10 Entry $20.89 Now $20.49 −1.91% settles Feb 16
  3. Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $20.84 Now $20.49 −1.68% settles Feb 12
  4. Nov 6, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $19.91 Now $20.49 +2.91% settles Feb 4
  5. Nov 5, 202612d ago 8-K Mixed 6/10 Entry $18.97 Now $20.49 +8.01% settles Feb 3
  6. Nov 4, 202613d ago Press Release Neutral 2/10 Entry $19.22 Now $20.49 +6.61% settles Feb 2
  7. Oct 30, 202618d ago Press Release Bullish 6/10 Entry $19.04 Now $20.49 +7.64% settles Jan 28
  8. Oct 29, 202619d ago Institutional Cluster Bullish 4/10 Entry $19.20 Now $20.49 +6.72% settles Jan 27
  9. Oct 16, 20264w ago Press Release Bullish 6/10 Entry $18.26 Now $20.49 +12.21% settles Jan 14
  10. Oct 8, 20265w ago 8-K Bullish 7/10 Entry $17.44 Now $20.49 +17.49% settles Jan 5
Showing 10 of 22

US Market Status

Market Open · Closes in 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026